[
  {
    "ts": null,
    "headline": "3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever",
    "summary": "Temporary turbulence has resulted in opportunity for patient, bargain-hunting investors.",
    "url": "https://finnhub.io/api/news?id=3c520112dfe389f980f8ae48787a6f483facfbc7ba5dabdced6efd003bc63c78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747260300,
      "headline": "3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever",
      "id": 134460932,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Temporary turbulence has resulted in opportunity for patient, bargain-hunting investors.",
      "url": "https://finnhub.io/api/news?id=3c520112dfe389f980f8ae48787a6f483facfbc7ba5dabdced6efd003bc63c78"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Files Pricing Term Sheet For Four-Part Euro-Denominated EUR3.3 Billion Notes Offering",
    "summary": "Pfizer Inc: * PFIZER FILES PRICING TERM SHEET FOR FOUR-PARTEURO-DENOMINATED€3.3 BILLION NOTES OFFERING - SEC FILINGFurther company coverage: ...",
    "url": "https://finnhub.io/api/news?id=d1fb16b15712ff3ba37f77a46c1604a977ae3535a068180cb6f661e15c071f49",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747241543,
      "headline": "Pfizer Files Pricing Term Sheet For Four-Part Euro-Denominated EUR3.3 Billion Notes Offering",
      "id": 134454499,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer Inc: * PFIZER FILES PRICING TERM SHEET FOR FOUR-PARTEURO-DENOMINATED€3.3 BILLION NOTES OFFERING - SEC FILINGFurther company coverage: ...",
      "url": "https://finnhub.io/api/news?id=d1fb16b15712ff3ba37f77a46c1604a977ae3535a068180cb6f661e15c071f49"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over Pfizer",
    "summary": "Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and PFE stock and which one we prefer.",
    "url": "https://finnhub.io/api/news?id=387ff3f6523a6f26d030160f3e4d6f215b340a2df1c552ebbe9e52038422b53d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747240576,
      "headline": "Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over Pfizer",
      "id": 134454257,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168190/image_1886168190.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and PFE stock and which one we prefer.",
      "url": "https://finnhub.io/api/news?id=387ff3f6523a6f26d030160f3e4d6f215b340a2df1c552ebbe9e52038422b53d"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”",
    "summary": "We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks on Jim Cramer’s radar recently. On Monday’s episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor […]",
    "url": "https://finnhub.io/api/news?id=9c2082aae789029fa29cd53c162a1c76482a8971c231ef32f5ae059c6165e028",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747232153,
      "headline": "Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”",
      "id": 134461053,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks on Jim Cramer’s radar recently. On Monday’s episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor […]",
      "url": "https://finnhub.io/api/news?id=9c2082aae789029fa29cd53c162a1c76482a8971c231ef32f5ae059c6165e028"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer",
    "summary": "StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=420d918d90b0468a522f750f52ad9dc45c4d0a1151f038670dfd01d413896ae8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747223160,
      "headline": "Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer",
      "id": 134461054,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=420d918d90b0468a522f750f52ad9dc45c4d0a1151f038670dfd01d413896ae8"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.",
    "summary": "Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.",
    "url": "https://finnhub.io/api/news?id=8ab9dcccbd821b4af88441cd016dbca2988656c853d954eedc4541b773e0ce23",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747218240,
      "headline": "Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.",
      "id": 134437591,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.",
      "url": "https://finnhub.io/api/news?id=8ab9dcccbd821b4af88441cd016dbca2988656c853d954eedc4541b773e0ce23"
    }
  },
  {
    "ts": null,
    "headline": "Court annuls European Commission's refusal to disclose COVID texts",
    "summary": "* NY Times seeking access to texts between Commission andPfizer * Commission's Von der Leyen says texts not in herpossession * Transparency...",
    "url": "https://finnhub.io/api/news?id=1aa54ef118567792bdbac4a20716dc601fcc75313aac38f968394446d8bb46a5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747211875,
      "headline": "Court annuls European Commission's refusal to disclose COVID texts",
      "id": 134435332,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "* NY Times seeking access to texts between Commission andPfizer * Commission's Von der Leyen says texts not in herpossession * Transparency...",
      "url": "https://finnhub.io/api/news?id=1aa54ef118567792bdbac4a20716dc601fcc75313aac38f968394446d8bb46a5"
    }
  },
  {
    "ts": null,
    "headline": "How Our High-Yield Portfolio Beats The S&P 500",
    "summary": "It is possible to build a high-yield equity portfolio that outperforms the S&P 500 with dividend-focused strategies. Read more about how to create such a high-yield portfolio.",
    "url": "https://finnhub.io/api/news?id=bd500286602ea8738ab30e113e7701f6f3468f1ce19b2f09b24c3e8dd4463d6b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747209856,
      "headline": "How Our High-Yield Portfolio Beats The S&P 500",
      "id": 134435285,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1377760359/image_1377760359.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "It is possible to build a high-yield equity portfolio that outperforms the S&P 500 with dividend-focused strategies. Read more about how to create such a high-yield portfolio.",
      "url": "https://finnhub.io/api/news?id=bd500286602ea8738ab30e113e7701f6f3468f1ce19b2f09b24c3e8dd4463d6b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Bearish Catalysts Brewing",
    "summary": "Pfizer: Bearish Catalysts Brewing",
    "url": "https://finnhub.io/api/news?id=19bd4f5fa7a82282edf9d9e8a1da260fe746d3392f3e2c5045672221289f4cb5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747207800,
      "headline": "Pfizer: Bearish Catalysts Brewing",
      "id": 134434883,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=19bd4f5fa7a82282edf9d9e8a1da260fe746d3392f3e2c5045672221289f4cb5"
    }
  },
  {
    "ts": null,
    "headline": "Court rejects European Commission's refusal to share COVID messages with NY Times",
    "summary": "BRUSSELS, May 14 - ...",
    "url": "https://finnhub.io/api/news?id=4d8df71fe68ffa251fa901edeb3ab0ebef612aa3f4af72e865e3e4647a1412c2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747199839,
      "headline": "Court rejects European Commission's refusal to share COVID messages with NY Times",
      "id": 134433645,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "BRUSSELS, May 14 - ...",
      "url": "https://finnhub.io/api/news?id=4d8df71fe68ffa251fa901edeb3ab0ebef612aa3f4af72e865e3e4647a1412c2"
    }
  },
  {
    "ts": null,
    "headline": "3 Value Stocks Facing Headwinds",
    "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
    "url": "https://finnhub.io/api/news?id=b10b81b7a023d38e5f4322f16d22738418f6fd1253c5f937f6c5a16a5f17f70b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747197331,
      "headline": "3 Value Stocks Facing Headwinds",
      "id": 134461055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
      "url": "https://finnhub.io/api/news?id=b10b81b7a023d38e5f4322f16d22738418f6fd1253c5f937f6c5a16a5f17f70b"
    }
  },
  {
    "ts": null,
    "headline": "EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer",
    "summary": "BRUSSELS -Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and...",
    "url": "https://finnhub.io/api/news?id=a3ef903e904f95b6ed0468a02089b0299652b34d7d6b87de30a89564bc78bc09",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747194131,
      "headline": "EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer",
      "id": 134432866,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "BRUSSELS -Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and...",
      "url": "https://finnhub.io/api/news?id=a3ef903e904f95b6ed0468a02089b0299652b34d7d6b87de30a89564bc78bc09"
    }
  }
]